Sunscreen Innovation Act Illuminates ‘Good Things’ For OTC Monograph Reform
This article was originally published in The Tan Sheet
Executive Summary
The Sunscreen Innovation Act’s more efficient process provides a model for OTC monograph reform, says nonprescription drugs office chief Theresa Michele. At a CHPA conference, she says a key change under the act is eliminating some administrative steps required for other monograph proposals.
You may also be interested in...
FDA Denies Remaining Sunscreen TEAs, Offers Primer On GRASE, Resources
FDA denies sunscreen TEAS for L'Oreal and Merck & Co., citing data gaps, according to proposed orders. Proponents of launching additional ingredients say the decisions point to continued gridlock in changing FDA’s OTC sunscreen monograph.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.